July 2021 - Page 38 of 41

FridayJul 02, 2021 10:53 am

Predictive Oncology Inc. (NASDAQ: POAI) Stands Strong as Innovator, Leader in Precision Medicine

Company plans to use proceeds from direct offering for business development, drug repurposing and discovery and expansion of its laboratory facilities POAI portfolio spans four different subsidiaries, including list of assets rivaling best operators in the space Predictive Oncology is strong standout in precision medicine Predictive Oncology (NASDAQ: POAI) has closed on its registered direct offering (https://ibn.fm/9buhx).The offering, which totaled $21.34 million, will be a boon for the knowledge-driven company as it continues its focus on applying artificial intelligence (“AI”) to personalized medicine and drug discovery. Operating in the AI space, the company is looking at almost vast potential as…

FridayJul 02, 2021 10:38 am

QualityStocksNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Bringing Researchers Next-Level Tools for Hard-to-Treat Diseases

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is looking to give oncology drug developers an upper hand, thereby increasing the chances of the drugs’ success from the onset. “Raising the success rate for experimental cancer drugs starts in the laboratory, where leading-edge technology could be instrumental in providing prescient insights that ultimately result in better clinical outcomes,” reads a recent article. TumorGenesis, a subsidiary of POAI, has partnered with Swedish cell culture system company Cellevate AB. “The collaboration will involve using TumorGenesis’ expertise in cancer cell culture growth…

FridayJul 02, 2021 10:20 am

QualityStocksNewsBreaks – Brain Scientific Inc.’s (BRSF) Pediatric NeuroCap Is First-of-its-Kind for Pediatric Market

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, is bringing to market new technology that allows EEG testing to be deployed rapidly and accurately in children and adolescents. The Pediatric NeuroCap is intended to solve significant barriers limiting EEG monitoring in pediatric care. “Instead of improvising to make adult-size EEG electrodes fit pediatric patients’ smaller head circumference, Brain Scientific fully adapted its revolutionary NeuroCap to be used in children,” reads a recent article. “The Pediatric NeuroCap comes in two sizes and includes 22 integrated, pre-gelled electrodes compliant with the 10-20 international system. With the…

FridayJul 02, 2021 10:19 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Share its Drug Development Pipeline and the Company’s Progress in the Psych Investor Summit

Tryp Therapeutics will be participating in the second global Psych Investor Summit: Research and Development The virtual presentation is scheduled for July 7 from 11:50 a.m. to 12:50 p.m. EDT It will focus on the psychedelics industry, showcasing the latest research and development within the sector Mr. Greg McKee, Chairman and CEO of Tryp Therapeutics, will share information on the company, along with its drug development pipeline In an official statement dated June 24, 2021, Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) confirmed that it would participate in the Psych Investor Summit: Research and Development. The virtual event, scheduled on Wednesday,…

FridayJul 02, 2021 9:59 am

QualityStocksNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announces the Postponement of FY2021 Earnings Report, Conference Call

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), a producer of premium bottled alkaline water, flavor-infused waters and CBD-infused products sold under the brand names Alkaline88(R), A88 Infused(TM) and A88CBD(TM), announced that the company has not filed its 10-K full-year fiscal year 2021 earnings results. As a result, the company has postponed its earnings call. The company is recognized for its flagship product, Alkaline88, which features an innovative, state-of-the-art proprietary electrolysis process and delivers perfect 8.8 pH balanced alkaline drinking water with trace minerals and electrolytes. The company also offers a line of flavor-infused beverages and a line of CBD-infused products that…

FridayJul 02, 2021 9:45 am

Ideanomics Inc. (NASDAQ: IDEX) Boosts EV Tractor Acquisition to 100 Percent, Anticipating Growing Potential for Environmental Awareness in Agriculture Industry

Despite the worldwide economic difficulties imposed by the pandemic during the past year, new efforts at electric vehicle adoption are on the rise Ideanomics recently announced 100 percent acquisition of EV tractor manufacturer and distributor Solectrac Inc., which will grant it premium positioning in the agriculture industry’s growing interest in zero-emissions vehicles Ideanomics is also celebrating the launch of Technology Metals Market (“TM2”) trading using Nasdaq's cloud-deployed matching technology for real-time pricing Consumer interest in reducing the harmful effects of pollutants on the earth’s climate globally has led to a resurgence of electric-driven automotive technology in the world’s marketplace for…

FridayJul 02, 2021 9:26 am

QualityStocksNewsBreaks – Petroteq Energy Inc. ‎‎(TSX.V: PQE) (‎OTC: PQEFF) (FSE: PQCF) Outlines Planned Debt Conversions

Petroteq Energy ‎‎(TSX.V: PQE) (‎OTC: PQEFF) (FSE: PQCF), an integrated oil ‎company focused on the development and implementation of its proprietary oil-‎extraction and remediation technologies, plans to complete debt conversion transactions. According to the announcement, the transactions will involve two arm’s length lenders, to which PQEFF will issue 2,333,176 common shares for $0.094 per share. The transactions will be in satisfaction of $219,318.33, representing both accrued and unpaid interest under previously issued convertible debentures. The company also plans to complete debt conversion transactions with four directors and one former director. Those transactions will involve an additional 862,456 common shares offered…

ThursdayJul 01, 2021 3:21 pm

QualityStocksNewsBreaks – FingerMotion Inc. (FNGR) Leverages Expansion Resolve, Telecom Partnerships to Build Platform

FingerMotion (OTCQX: FNGR) recently released its financial results for the fiscal year ended February 28, 2021, posting “its highest revenue and year-over-year revenue growth thus far.” According to a recent article, the company’s revenue grew by 82% from the previous financial year 2020, reaching $16.68 million. FNGR’s SMS and MMS segment posted business revenue of $6.13 million for the 2021 fiscal year, an 84% growth from the year before. Its gross profit increased by 71%. The company’s overall growth for the 2021 financial year reflected $2.11 million in positive shareholders’ equity. The article continues, “The 2021 impressive fiscal performance was…

ThursdayJul 01, 2021 2:47 pm

QualityStocksNewsBreaks – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Finalizing Design of Innovative Cancer Visualization Technology

Imagin Medical (CSE: IME) (OTCQB: IMEXF) is finalizing the design of its i/Blue Imaging System(TM), with manufacturing expected to be completed in 2022. The system is an innovative technology designed to significantly improve surgeons’ ability to visualize cancerous cells and enable more accurate bladder cancer resection. It solves challenges associated with using blue and white light cystoscopies, which require surgeons to switch back and forth between images and rely on memory to resect. “The company’s advanced technology will show both images simultaneously side-by-side on one screen, providing surgeons with better visualization to remove the cancer and making procedures more efficient,”…

ThursdayJul 01, 2021 1:58 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc.’s (PBIO) UST(TM) Platform Delivers Breakthrough Results Processing One of the Most Powerful Antioxidants Known to Science

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform technology solutions to the worldwide biotechnology and other industries, today announced the successful application of its Ultra Shear Technology(TM) (“UST(TM)”) platform. According to the update, the novel UST platform was used for the development of more potent formulations of wide-ranging nutraceuticals of high therapeutic value, allowing for more controlled dosing and opportunities for lower cost solutions for both manufacturers and consumers. Specifically, PBI reported breakthrough results in processing one of the most powerful antioxidants known to science, astaxanthin (“AsX”), in…

Site Search

Company Search

Month: July 2021